The biphasic wear performance (run-in; steady-state phase) of 28-mm alumina-alumina hip implants was studied by hip simulator methods using bovine serum as the lubricant. The Biolox implants were run to 5.7 million cycles and Bioceram implants to 14.4 million cycles (Mc). Wear with all-alumina total hip replacements (THR) first showed a high wear rate of the order 1.2 mm3/Mc, lasting approximately 0.17 Mc. Overall to 0.7 Mc, the run-in phase appeared curvilinear but could be described by a linear phase averaging 0.3 mm3/Mc. From 0.7 to 1 Mc duration, the wear trend transitioned into a steady-state phase. Wear rates from 1 to 14 Mc were of the order 0.02 mm3/Mc. Surface contamination from the serum lubricant resulted in cyclic weight fluctuations of the order 0.2 mg. The transition from average run-in to steady-state phase represented a wear reduction of 13-fold. Comparing the steady-state wear value to that in standard 28-mm UHMWPE CUPS approaching 75 mm3/year, there was clearly a three-orders-of-magnitude wear superiority in favor of ceramic cups.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jbm.a.30021 | DOI Listing |
Pharmaceutics
January 2025
Medical Faculty Heidelberg, Heidelberg University, 69117 Heidelberg, Germany.
: Bempedoic acid (BA) is a novel cholesterol-lowering agent with proven positive effects on cardiovascular endpoints. Because it is an inhibitor of the hepatic transporters OATP1B1 and OATP1B3, two uptake transporters regulating the intrahepatic availability of statins, it increases the systemic exposure of co-administered statins. This interaction could raise the risk of myopathy.
View Article and Find Full Text PDFClin Transl Gastroenterol
January 2025
Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
Introduction: We assessed potential mechanisms behind the requirement for more frequent dupilumab dosing in eosinophilic esophagitis (EoE) compared with other approved indications.
Methods: Results for the phase 3 LIBERTY EoE TREET study coprimary endpoints (proportion of patients achieving a peak intraepithelial eosinophil count of ≤6 eosinophils per high-power field and absolute change from baseline in Dysphagia Symptom Questionnaire total score) were pooled in exposure-response analyses.
Results: A steep initial relationship then plateau was observed between higher dupilumab steady-state trough concentrations and decreased eosinophilic infiltration at week 24, whereas a graded exposure-response relationship was observed for symptomatic improvement at week 24.
Res Pract Thromb Haemost
January 2025
Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Background: Emicizumab, a bispecific antibody that mimics factor (F)VIII, has significantly improved hemophilia A management. Although emicizumab levels can be measured, tools for estimating the hemostatic efficacy of emicizumab are lacking. Thrombin generation (TG) assays can distinguish bleeding phenotypes in persons with hemophilia A on FVIII prophylaxis and may also be used during emicizumab therapy.
View Article and Find Full Text PDFWater Res
January 2025
Department of Civil and Environmental Engineering, University of Florence, Via di S. Marta, 3, 50139, Firenze, Italy.
The performance of Upflow Anaerobic Sludge Blanket (UASB) bioreactors treating sulfate (SO) -rich effluents depends on multiple factors, including microbial interactions and operational conditions. The high complexity of these systems necessitates the use of mathematical modelling tools to better understand the process and predict the long-term impacts of various operational variables. In this work, a mathematical model describing the long-term operation of a sulfate-fed 2.
View Article and Find Full Text PDFJ Magn Reson Imaging
January 2025
Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: Hemodynamic force (HDF) from cardiac MRI can indicate subclinical myocardial dysfunction, and help identify early cardiac changes in patients with Fabry disease (FD). The hemodynamic change in FD patients remains unclear.
Purpose: To explore HDF changes in FD and the potential of HDF measurements as diagnostic markers indicating early cardiac changes in FD.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!